IL10 and myocardial infarction: Recently, several clinical trials have been performed and novel therapeutic tools developed with the aim of targeting either IL-10 or IL-6 against MI-induced cardiac damage [3,52], which could correct the imbalance between the pro-and anti-inflammatory phases and thus accelerate cardiac healing.